• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Addiction >Factors Influencing Buprenorphine Prescribing among Physicians in New York State
【24h】

Factors Influencing Buprenorphine Prescribing among Physicians in New York State

机译：影响纽约州医生丁丙诺啡的因素

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background. Increasing access to buprenorphine is an important strategy for curtailing the opioid epidemic. Research is needed to understand what facilitates prescribing among waivered physicians and how to increase the willingness and capacity to prescribe. This study describes prescribing patterns in a sample of buprenorphine-waivered physicians in New York (NY) in 2016 and examines factors influencing prescribing capacity among waivered providers. Methods. Surveys were mailed to a random sample of 300 physicians with DEA waivers to prescribe buprenorphine in NY which assessed demographics, practice characteristics, buprenorphine prescribing patterns, and barriers/facilitators to prescribing buprenorphine. Analyses include simple logistic regression to calculate the odds ratio, 95% confidence intervals, and p values, respectively, to examine differences in individual predictors among physicians that were actively prescribing buprenorphine and those that were not. Results. 91 physicians responded to the survey, and 65% indicated they were currently prescribing buprenorphine. The mean patient census among physicians waivered to prescribe to 30 patients was 9.6 (SD?=?9.7, median?=?5), and to 100 patients, it was 60.5 (SD?=?38.9, median?=?72.5). Common facilitators included access to psychosocial referrals and better reimbursement, while inadequate resources, lack of time, and prior authorizations were the most common barriers. Conclusions. In addition to increasing the number of waivered physicians, policy-makers should provide enhanced training and implementation support for waivered physicians to start prescribing and facilitate continued and expanded prescribing among those already doing so.
机译：背景。越来越多地进入Buprenorphine是缩减阿片类化疫情的重要策略。需要研究以了解可被豁免的医生处方以及如何提高规定的意愿和能力。本研究介绍了2016年纽约（纽约州）在纽约（纽约）的丁尼啡啡杂交医生样本中规定模式，并检查了减免提供者之间的处方能力的因素。方法。调查被邮寄到300个医生的随机样本，其中DEA豁免在纽约中规定杜林啡啡，这评估了人口统计，实践特征，丁丙诺啡规定模式，障碍/促进者对处方丁丙诺啡的障碍/促进者。分析包括简单的逻辑回归，以分别计算赔率比，95％置信区间和P值，检查医生中的个体预测因子的差异，这些预测因子正在主动处方培养丙甲啡和那些没有的人。结果。 91家医生回应了调查，65％表示他们目前处于规定的Buprenorphine。被免除的医师之间的平均患者人口普查排除30名患者是9.6（SD？=？9.7，中位数？=？5）和100名患者，它是60.5（SD？=？38.9，中位数？=？72.5）。常见的促进者包括获得心理社会转介和更好的报销，而资源不足，缺乏时间和事先授权是最常见的障碍。结论。除了增加减少医生的次数外，政策制定者还应提供加强的培训和实施支持，因为减少医生开始处方，促进在已经这样做的那些已经继续并扩大规定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号